Product Overview
TrialKey transforms clinical trial design with unparalleled speed and precision. Leveraging 100,000 simulations against over 30+ years of global trial data, our AI-driven biostatistical validation delivers insights that traditional methods can’t match.
With advanced computational simulations, explainable AI, and predictive modelling, TrialKey eliminates inefficiencies, scales effortlessly, and ensures regulatory alignment—providing the fastest, most reliable path to optimised trial success.
Create Optimal Trials Designs
We automate protocol creation by applying data-driven insights to define inclusion criteria, endpoints, and site selection.
Optimise Existing Trials
Fine-tunes trial parameters to minimize risks, reduce timelines, and improve outcomes.
Predict Outcomes
Simulates various scenarios to forecast trial success and resource allocation with high confidence.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Market-leading +92% precision in predicting primary endpoint completion
Our platform is trained using data from over 520,000 clinical trials and 1500+ variables.
Each trial is simulated up to 100,000 times provides robust, reliable predictions, ensuring data-driven biostatistical validation for optimised trial designs and advanced AI detective work on unstructured data (clinician notes, company filings, press cuttings)—TrialKey fills critical knowledge gaps to deliver robust, real-world trial prediction
About the company
Opyl’s mission is to make a meaningful difference in medicine by leveraging AI to refine recommendations, optimise trial designs, and pioneer innovative solutions that address broader medical challenges.
Our vision is to be the leading platform for clinical trial design optimisation and prediction worldwide. We partner with the top contract research organisations, pharmaceutical and biotechnology companies, and industry experts to accelerate medical innovation and bring treatments to market faster
